help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosenfeld, R. G.
Right arrow Articles by Ocrant, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosenfeld, R. G.
Right arrow Articles by Ocrant, I.

Endocrinology, Vol 124, 2867-2874, Copyright © 1989 by Endocrine Society


ARTICLES

Characterization of insulin-like growth factor-binding proteins in cultured rat pituitary cells

RG Rosenfeld, H Pham, Y Oh and I Ocrant
Department of Pediatrics, Stanford University Medical Center, California 94305.

Binding proteins (BPs) for the insulin-like growth factors (IGFs) produced by cultured rat anterior pituitary (AP) and neurointermediate lobe (NI) cells were studied by competitive binding, affinity cross- linking, and Western ligand blot techniques. Conditioned medium from AP cultures contained specific high affinity IGF BPs with apparent mol wt of 35K, 27K, and 24K, while the 27K BP predominated in NI conditioned medium. Treatment of AP and NI conditioned media with endoglycosidase-F did not alter the 27K BP, but significantly reduced the apparent mol wt of the 35K BP into the 27-29K range, suggesting that the 35K BP may be a glycosylated form of the 27K BP. This 27K pituitary BP appeared similar to the BP produced by BRL-3A cells in both size and apparent lack of glycosylation. Although type 2 IGF receptors could be identified in conditioned medium from NI and GH3 pituitary cells, binding of [125I]IGF to pituitary BPs could not be inhibited, nor could the cross-linked BPs be immunoprecipitated, by antibody against the type 2 receptor. We conclude that cultured AP and NI cells produce a variety of related IGF BPs that are structurally distinct from the type 2 IGF receptor.


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
T. C. Voss, M. P. Flynn, and D. L. Hurley
IGF-I Causes an Ultrasensitive Reduction in GH mRNA Levels via an Extracellular Mechanism Involving IGF Binding Proteins
Mol. Endocrinol., September 1, 2001; 15(9): 1549 - 1558.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Stefaneanu, L. Powell-Braxton, W. Won, V. Chandrashekar, and A. Bartke
Somatotroph and Lactotroph Changes in the Adenohypophyses of Mice with Disrupted Insulin-Like Growth Factor I Gene
Endocrinology, September 1, 1999; 140(9): 3881 - 3889.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
J.A. Clapper, J.L. Snyder, A.J. Roberts, D.L. Hamernik, and G.E. Moss
Estradiol Increases Relative Amounts of Insulin-Like Growth Factor Binding Protein (IGFBP)-3 in Serum and Expression of IGFBP-2 in Anterior Pituitaries of Ewes
Biol Reprod, July 1, 1998; 59(1): 124 - 130.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
S. Rajaram, D. J. Baylink, and S. Mohan
Insulin-Like Growth Factor-Binding Proteins in Serum and Other Biological Fluids: Regulation and Functions
Endocr. Rev., December 1, 1997; 18(6): 801 - 831.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society